Mesenchymal stem cell gel for improving healing of burn skin grafts
Official title: A Randomized Controlled Study on the Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Extensive Burns
Run by The First Affiliated Hospital of Xinxiang Medical College · NCT07580755 · Data updated 2026-11-12
This study will test whether applying a low- or high-dose mesenchymal stem cell gel to donor skin sites helps them heal faster and with better outcomes after autologous skin grafting in adult burn patients.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | The First Affiliated Hospital of Xinxiang Medical College Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Xinxiang, Henan) |
| Status | Recruiting |
| Started | April 27, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | May 12, 2026 |
| Trial ID | NCT07580755 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with burn injuries needing autologous medium-thick skin grafts (donor area lateral thigh or trunk), with total burn area under 30% TBSA and an excised flap area ≥90 cm2, who can consent and comply with follow-up.
✕Probably not a fit
Patients with electric, chemical, or radiation burns or other major trauma, those allergic to the gel component (sodium alginate), pregnant or breastfeeding people, or those with severe systemic disease or uncontrolled hypertension/diabetes are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, double-blind, parallel-controlled trial enrolling 90 adult burn patients undergoing autologous medium-thick skin grafting. Participants are randomized 1:1:1 to receive a low-dose stem cell gel, a high-dose stem cell gel, or a placebo gel applied to donor/treated skin sites, with 30 patients per group. All groups receive the same surgical and postoperative care and attend regular follow-up visits per protocol. The trial is conducted at a single center and focuses on wound healing outcomes after graft harvest and transplantation.
Why it matters
Potential benefit: If successful, the stem cell gel could speed healing of graft sites, reduce complications, and improve cosmetic and functional outcomes for burn patients.
How similar studies have gone: Similar approaches using mesenchymal stem cells or cell-based dressings have shown promising results in preclinical studies and small clinical series, but robust randomized evidence is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Voluntary participation and signing of the informed consent form; 2. Burn patients, subjects requiring autologous skin grafting; 3. Age 18 to 65 years old, gender not restricted; 4. During this clinical study, single person, single donor skin area (lateral thigh or trunk) treatment; 5. Skin burn area \< 30% of total body surface area (TBSA); 6. The donor skin area is the first time for donation, and the donor skin area is medium-thick skin (thickness approximately 0.4mm); 7. The area of the excised skin flap ≥ 90 cm2; 8. Able to cooperate with this study protocol and accept regular postoperative follow-up visits. Exclusion Criteria: 1. Those allergic to sodium alginate (gel component); 2. Electric shock injuries, chemical burns, radiation injuries or combined with other traumas; 3. Subjects with severe systemic diseases (judged by the researchers); 4. Subjects with uncontrolled hypertension or diabetes (judged by the researchers); 5. Pregnant or lactating women; 6. Subjects whose condition may affect the study assessment or require the concurrent use of medical treatments that may affect the efficacy assessment; 7. Subjects with acute or chronic kidney diseases, renal failure or serum creatinine level = 1.5 times the upper limit of normal value; 8. Subjects with acute or chronic liver diseases, total bilirubin, alanine aminotransferase, aspartate aminotransferase = 2.0 times the upper limit of normal value; 9. Subjects with a history of malignant tumors; 10. Subjects who have participated in other clinical studies for less than 3 months; 11. Subjects with mental disorders and without self-awareness, unable to express clearly; 12. Subjects using immunosuppressants and those who have been using corticosteroids for a long time (more than 1 month) (excluding local application); 13. Subjects with infectious diseases (any one of the four items positive in the test); 14. Subjects with other severe systemic diseases; 15. Other subjects that the researchers consider not eligible for inclusion.
Where it's running
-
The First Affiliated Hospital of Xinxiang Medical College
Xinxiang, Henan, China Recruiting
Study contacts
- Study coordinator: Wenjie Ren
- Email: 13937354075@163.com
- Phone: 13937354075
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Burn Injury and Cellular Energy in Kids and Adults
This study tests how a burn injury affects cellular energy in patients admitted for burn care at Arkansas Children’s Hospital.
-
VR-enhanced progressive muscle relaxation for chronic symptoms after burn injury
This will try progressive muscle relaxation with and without virtual reality to see if it helps adult burn survivors reduce chronic pain, itch, anxiety, sleep problems, or fatigue.
-
Plasma Resuscitation Early for Severe Burn Injury
This trial tests whether starting plasma resuscitation right at hospital arrival helps adults with large burns recover better than standard fluids.
-
How a large simulated burn affects cooling down after exercise in hot conditions
This project will test whether covering 60% of the body to simulate a burn makes healthy adults take longer to cool down after exercising in the heat.
-
How heat and humidity affect core temperature during work-rest cycles in burn survivors
This project will test whether heat and humidity change core body temperature during repeated 30-minute exercise and rest cycles in adults who had major burns (≥20% body surface) and in non-burned controls.
-
Comparing High Flow Nasal Oxygen and Nasal Cannula for Burn Patients Under Sedation
This study is testing whether high flow nasal oxygen can help burn patients breathe better during surgery compared to standard nasal oxygen.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.